Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Your loved one’s cognitive test results came back with two different scores from two different tests taken weeks apart—and now you’re confused about which one reflects their true cognitive status. This situation happens more often than you might realize, and there’s a straightforward explanation: the Montreal Cognitive Assessment (MoCA) and the Mini-Mental State Examination (MMSE) are fundamentally different tools, designed with different purposes and scoring approaches. When results don’t match, it’s rarely because one test made an error—it’s because they’re measuring cognition differently and with different levels of sensitivity to early decline. The core reason results diverge is that MoCA is significantly better at detecting mild cognitive impairment, catching subtle deficits that MMSE often misses.
While MMSE demonstrates sensitivity between 18-78% for mild cognitive impairment, MoCA achieves 90% sensitivity for the same condition. This means if someone has early cognitive decline, MoCA is far more likely to flag it. Additionally, MoCA routinely produces lower scores than MMSE—average scores of 25.62±3.84 on MoCA compared to 28.31±1.92 on MMSE—which is why the same person might score “normal” on MMSE but show concerns on MoCA. Understanding these differences is critical for patients and caregivers interpreting test results and making informed decisions about care and follow-up monitoring.
Table of Contents
- What Makes MoCA and MMSE Measure Differently?
- Why MoCA Scores Are Consistently Lower Than MMSE Scores
- The Executive Function Gap—What MMSE Misses in Early Decline
- Choosing the Right Test for Your Situation—Timing and Purpose Matter
- The Education Correction Factor and Why It Matters for Fair Assessment
- Clinical Cutoff Scores and Why “Normal” Differs Between Tests
- What the Future Holds—Emerging Consensus on Cognitive Screening
- Conclusion
What Makes MoCA and MMSE Measure Differently?
The two tests diverge most significantly in their assessment of executive function, the cognitive domain responsible for planning, problem-solving, and abstract thinking. The mmse, developed in the 1970s, was designed as a rapid screening tool focusing on orientation, memory, and basic language. The MoCA, created decades later, intentionally added components the MMSE lacks: Trail Making Test B (measuring processing speed and cognitive flexibility), clock drawing (evaluating visuospatial and executive abilities), and abstraction testing. These executive function domains are often the first to show decline in early cognitive impairment, which is why MoCA catches problems MMSE misses. Consider a real clinical scenario: a 72-year-old man with early Alzheimer’s disease takes both tests within a month.
On the MMSE, he scores 27/30—in the “normal” range—because he correctly answers orientation and memory questions. But on the MoCA, his score drops to 23/30 because he struggles with the Trail Making Test B (he becomes confused switching between numbers and letters) and the clock drawing task (his clock is disorganized). His executive function deficits revealed by MoCA would have gone completely undetected by MMSE alone. This is not a testing error; it reflects the fundamentally different cognitive domains each test evaluates. The MMSE’s older design makes it less sensitive to subtle, early-stage impairment, while MoCA’s broader scope catches these early warning signs.
Why MoCA Scores Are Consistently Lower Than MMSE Scores
Part of the confusion around differing results stems from the simple fact that MoCA and MMSE use different scoring frameworks and assess different cognitive breadth. Research consistently shows mean MMSE scores approximately 2.7 points higher than mean MoCA scores in the same populations. This isn’t because MoCA is harder in a punitive way, but because it includes more cognitive domains, and patients are more likely to show weakness in at least one area when more ground is covered. The practical implication for caregivers is that you cannot directly compare absolute scores between the two tests.
A score of 27 on MMSE does not equal a score of 27 on MoCA. A patient scoring 26 on MMSE (typically considered normal) might score 22 on MoCA (below the cutoff of 26 for normal cognition on the MoCA), triggering a referral for further evaluation. This is actually working as intended—MoCA’s lower baseline sensitivity ensures that subtle cognitive changes aren’t missed. However, this can feel misleading to families who expect the same test result to remain stable if taken on different days or with different assessments.
The Executive Function Gap—What MMSE Misses in Early Decline
Executive function problems often signal the earliest stages of cognitive disease, particularly in frontotemporal dementia and Lewy body dementia, but can appear early even in Alzheimer’s disease. The MMSE simply doesn’t test this domain adequately. MoCA’s inclusion of executive function testing—specifically through Trail Making Test B (switching between alternating sequences) and clock drawing (organizing spatial information)—makes it substantially more sensitive to these early changes. A person might maintain perfect orientation and memory (MMSE strength areas) while losing the ability to organize complex tasks or switch mental sets (MoCA-detected deficits).
One limitation to be aware of: MoCA’s greater sensitivity for mild cognitive impairment comes at the cost of slightly lower specificity. MoCA shows 87% specificity for MCI detection compared to MMSE’s 100% specificity, meaning MoCA has a marginally higher false-positive rate. This means some people screened with MoCA might be flagged as having cognitive concerns when they don’t actually have underlying pathology. This is why a single abnormal MoCA score should prompt follow-up with a neuropsychological evaluation rather than immediate disease diagnosis—MoCA screens for risk, it doesn’t diagnose.
Choosing the Right Test for Your Situation—Timing and Purpose Matter
The test selection should ideally match the clinical question being asked. If the goal is rapid screening in a busy primary care office, MMSE’s 7-10 minute administration time makes practical sense. But if the goal is detecting early cognitive change or ruling out subtle impairment, MoCA’s more thorough 10-15 minute assessment is worth the extra time. Many dementia specialists now prefer MoCA precisely because they’re trying to catch decline early, when interventions may be most effective.
A practical consideration: insurance coverage and clinician familiarity sometimes drive test selection more than optimal methodology. MMSE has been around longer and is more widely covered, so some primary care doctors default to it. But if you receive an MMSE result that seems inconsistent with your concerns about cognitive changes, requesting a MoCA may reveal a different picture. The two tests serve different purposes—MMSE is a rapid screen for significant impairment, while MoCA is a more sensitive tool for detecting early decline.
The Education Correction Factor and Why It Matters for Fair Assessment
MoCA includes an education correction that MMSE does not: one point is added to the MoCA score for individuals with 12 years or fewer of formal education. This is an important acknowledgment that educational attainment affects cognitive test performance independent of actual cognitive ability. Someone with a high school education might score lower on certain cognitive tasks simply due to less exposure to academic reasoning patterns, not because they have cognitive decline.
This correction introduces another variable that can explain score discrepancies between the two tests. A person with 11 years of education taking MMSE gets no adjustment, but when taking MoCA, one point is added to their score. This built-in fairness mechanism in MoCA is positive for equity, but it also means the two tests adjust for educational differences differently—yet another reason the same person might score differently on each assessment. If your test results show MMSE performed worse than MoCA in a person with limited formal education, the MoCA’s education correction may partially explain the difference.
Clinical Cutoff Scores and Why “Normal” Differs Between Tests
The threshold scores that define “normal” versus “impaired” differ meaningfully between the tests. For the MoCA, a score of 26 or higher is generally considered normal cognition (though this may vary slightly by population). For the MMSE, scores above 23-24 are typically considered normal. But beyond these general guidelines, optimal cutoff scores vary by population and condition being screened.
For mild cognitive impairment detection in specific populations, studies have identified MoCA cutoffs of 24 (with 88% sensitivity and 74% specificity) as optimal in some groups, while dementia detection uses a cutoff of 20 for MoCA (79% sensitivity, 80% specificity). The existence of multiple cutoff scores for the same test in different populations means that “normal” is not a universal number—it’s contextual. Your age, education, cultural background, and even the specific clinical setting where you’re tested can influence which cutoff score your clinician uses to interpret your result. This is why a score of 23 on MoCA might be considered normal in one setting but flagged for concern in another, depending on the cutoff being applied.
What the Future Holds—Emerging Consensus on Cognitive Screening
The field is gradually shifting toward MoCA as a preferred screening tool, particularly in neurology and memory disorder clinics, because its superior sensitivity for early detection aligns with the modern understanding that early intervention matters. However, MMSE remains entrenched in many primary care and hospital settings due to familiarity and administrative inertia.
Rather than viewing these tests as competitors, modern practice increasingly uses them complementarily—a positive MMSE result may receive a follow-up MoCA for confirmation if clinical suspicion of early decline remains high. As cognitive screening evolves, additional tests are also entering the conversation, including the Montreal Cognitive Assessment-Basic (MoCA-B) and even computerized cognitive batteries. But for the foreseeable future, both MMSE and MoCA will remain common, and understanding their differences remains essential for patients and caregivers interpreting results and advocating for appropriate follow-up care.
Conclusion
The reason your test results don’t match is fundamentally due to differences in what the tests measure and how sensitively they detect cognitive change. MoCA’s superior sensitivity for mild cognitive impairment (90% versus 18-78% for MMSE) and its broader assessment of executive function make it more likely to flag early subtle decline, while MMSE’s older design focuses on more obvious impairment. The consistent scoring differences—roughly 2-3 points lower on MoCA than MMSE—reflect the broader cognitive ground covered by MoCA rather than a testing error.
When interpreting your own cognitive test results or those of someone in your care, remember that a single test result is not definitive. If results are unexpected or inconsistent with clinical impressions, asking for clarification on which test was used, discussing the clinical significance of the score in context of your age and education, and requesting follow-up assessment if concerns remain are all reasonable approaches. Your healthcare provider should be able to explain not just the score, but which specific cognitive domains were tested and why, and what the result means for next steps in monitoring and care.
